about
Oral fumaric acid esters for psoriasisOral fumaric acid esters for psoriasisRecent advances in understanding psoriasisThe role of hormones in the pathogenesis of psoriasis vulgarisThe neurotrophic receptor Ntrk2 directs lymphoid tissue neovascularization during Leishmania donovani infectionImmature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cellsVascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients.Expression of Angiogenic Factors in Psoriasis VulgarisIL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS eraIn silico discovery of potential VEGFR-2 inhibitors from natural derivatives for anti-angiogenesis therapy.Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and murine psoriasiform skin lesions.Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment.Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasisRole of the endothelium in inflammatory bowel diseases.In vitro and in vivo structure and activity relationship analysis of polymethoxylated flavonoids: identifying sinensetin as a novel antiangiogenesis agent.In vitro and in vivo evaluation of the anti-angiogenic actions of 4-hydroxybenzyl alcohol.Retinoic Acid promotes interleukin-4 plasmid-dimethylsulfoxide topical transdermal delivery for treatment of psoriasis.CARD14 expression in dermal endothelial cells in psoriasis.Clearing of psoriasis documented by laser Doppler perfusion imaging contrasts remaining elevation of dermal expression levels of CD31.Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis.18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.Telocyte dynamics in psoriasis.SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.The cutaneous vascular system in chronic skin inflammationPlants and their active compounds: natural molecules to target angiogenesis.Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral Acitretin.Upregulation of ANGPTL6 in mouse keratinocytes enhances susceptibility to psoriasis.A study of dermoscopic features of nail psoriasis.East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of Psoriasis.Nano to micro delivery systems: targeting angiogenesis in brain tumors.Role of endothelial chemokines and their receptors during inflammation.Psoriasis drug discovery: methods for evaluation of potential drug candidates.VEGF involvement in psoriasis.Impact of pregnancy and oestrogen on psoriasis and potential therapeutic use of selective oestrogen receptor modulators for psoriasis.Oxidative stress in psoriasis and potential therapeutic use of antioxidants.Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.Expression of pro-angiogenic genes in mesenchymal stem cells derived from dermis of patients with psoriasis.[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.
P2860
Q24187957-EBAD1E38-CCF6-457C-9DC3-1A702C380156Q24198185-1D7C80D9-1A78-4A97-AD75-0400AA01276FQ26751223-BB986E8E-C438-4D79-8CC6-F227427B1791Q26752733-BB200036-3D5D-406B-9A71-B3E400FD1258Q27321179-93E5F9C3-E650-4E11-A9A8-DD5B25E43A42Q28256749-2836DE05-3CE4-4F01-A630-271CE7156675Q30469815-F8A80AF1-B657-47DC-8D00-80BF63E1B3D5Q33631646-5353AF2D-0FFD-4DEF-8EEB-9CF4E3E1D8BCQ33666312-CB19DA70-9948-4901-AE67-50B145F63287Q33732911-31198326-CA86-459B-9E95-7E595DC9A4EDQ33768338-22A4C669-B7C0-48D5-A022-685BCE5A4B80Q34358658-51160C1A-A34B-48FB-8B53-3F30AA116D22Q34428875-18BD07B4-99A2-449D-98FC-138632F50659Q34504431-7F15FCA5-398C-4607-989B-5EACF1DC95A3Q34555643-5E97964B-D009-4E5D-ACDE-4B1629827F34Q34579746-E9405B8E-577C-4E2D-8BF7-9CFBBB9B83ADQ34639366-54ADF5D3-BF1F-48F0-9EBE-C9656F5F0BB7Q35036197-6A05D7DA-5D64-4D57-B594-5B4D924544EDQ35226768-AC9A9A2E-5DDC-4FBD-860A-00AB47A4BF42Q35392242-6FA60D51-72BE-4361-934B-ECE2087EA134Q35532791-51428B31-E545-4E75-85A5-8E5C65D48B36Q35763195-A4818FD7-23CD-4440-9CBA-F99886899549Q35784807-F8A2C421-55AC-41BB-A5FF-82FB7C59F031Q35879487-ED7D0FC4-13D4-40D8-8FC1-3A6890DB559CQ36085802-2C764170-33CD-4E7C-980C-51126FE2664AQ36098582-E7D6EFE7-77F7-4F03-9D34-383B1F85DEDCQ37059810-4DCFB353-527F-4300-81CA-5AB8BD32CE46Q37224890-2F9229DE-F5C8-41C4-876A-C665153901FEQ37306962-27A4F719-B6D8-4B27-AC48-15ABD04E4974Q37685557-161E7406-A15C-4DC6-B825-0A5A3352D71EQ37703061-403855FE-23C6-42D3-94D2-BC70C4957A1DQ37798870-A97FD514-8076-415F-BA63-F758DB283AB8Q37833076-3963F9C6-5E14-47CF-BAB3-2731E763A246Q37999088-36086EF9-9A1A-4208-ABBC-B4D9A987D0CAQ38648336-4FEF8294-8B8C-4E53-9C70-913EF8237E65Q38807000-35F76E97-D4AB-4821-8A12-55FB00713ED6Q38813221-E547814C-8CC0-4C59-B3AE-0213E49F8AB2Q38899075-BEAB6013-5300-4755-9FB9-E0619ACC5DA5Q38922644-124FDEC2-048F-4DD3-9279-3912AAECA06EQ39559499-1A5F81E4-2150-4231-BD0F-251D5C8FBC4A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiogenesis drives psoriasis pathogenesis.
@en
Angiogenesis drives psoriasis pathogenesis.
@nl
type
label
Angiogenesis drives psoriasis pathogenesis.
@en
Angiogenesis drives psoriasis pathogenesis.
@nl
prefLabel
Angiogenesis drives psoriasis pathogenesis.
@en
Angiogenesis drives psoriasis pathogenesis.
@nl
P2093
P2860
P1476
Angiogenesis drives psoriasis pathogenesis.
@en
P2093
Kamran Ghoreschi
Martin Röcken
Regina Heidenreich
P2860
P304
P356
10.1111/J.1365-2613.2009.00669.X
P577
2009-06-01T00:00:00Z